Shares Of This Micro Cap More Than Doubled Today

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, January 7, 2025

A New York-based biotech was turning heads during Tuesday’s session after the company announced that interim results from a phase 2a trial of its HT-001 showed that all patients met the primary efficacy endpoint.

Traders wasted no time scooping up shares of Hoth Therapeutics Inc. (Nasdaq:HOTH), with shares of the micro cap reaching up to $3.80/share (+363.64%) at the early session high. This move was a strong breakout from the multi-month downtrend this stock has been stuck in since April of last year.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Filing Pre-Submission with U.S. FDA Sends Shares Of This Biotech Higher

This Financial Stock Ripped At Mention Of AI Implementation

Another Day, Another Biotech Stealing The Show

This Financial Stock Ripped At Mention Of AI Implementation

Acquisition News Sends Micro-Cap Rallying Over 70%

U.S. Adds Tencent to Chinese Military Companies Blacklist

Taiwan Suspects a Chinese-Linked Ship of Damaging an Internet Cable

AllPennyStocks.com Favorites

This Tech Stock Could Be A Great Dip-Buying Opportunity

Enable Free Access to Unlock Up to Two Articles Per Month.

Compounding Pharmacies and a Quiet Gem with Surging Sales

Enable Free Access to Unlock Up to Two Articles Per Month.

Mural Oncology plc was a technical “one to watch” on Wednesday. Shares moved 5.19%, settling at $3.65 as the stock provided technicians with a Golden Cross (50 DMA / 200 DMA) technical signal.

Carbon Done Right Developments Inc. was an impressive gainer on the TSX-Venture on Wednesday. Shares climbed 200.00%, settling at $0.03.

OTC Markets listed, UAV was a standout in Wednesday's trade. The stock popped 75.00%, closing out the day at $0.02.

Gold Exploration in Northern Sweden: A High-Stakes Partnership in the Gold Line Belt

Enable Free Access to Unlock Up to Two Articles Per Month.

Gold Miner Comfortably Riding Upward Channel Pattern, More Upside Likely

Enable Free Access to Unlock Up to Two Articles Per Month.

WANT TO UNLOCK ACCESS TO:

●Stock Picks

●Penny Stocks to Watch

●"By The Numbers" Data Analytics

●Market Commentary

●Watch Lists

And much more by becoming an AllPennyStocks.com Free Member.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

Go Back

Email Registration

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2025 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

Shares Of This Micro Cap More Than Doubled Today

Other Penny Stock Movers

Filing Pre-Submission with U.S. FDA Sends Shares Of This Biotech Higher

This Financial Stock Ripped At Mention Of AI Implementation

Another Day, Another Biotech Stealing The Show

Most Popular

AllPennyStocks.com Favorites